Please use this identifier to cite or link to this item: https://doi.org/10.1080/03602530902741828
Title: Clinical pharmacology and pharmacogenetics of gemcitabine
Authors: Wong, A.
Soo, R.A. 
Yong, W.-P. 
Innocenti, F.
Keywords: Gemcitabine
Pharmacogenetics
Pharmacokinetics
Issue Date: May-2009
Source: Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F. (2009-05). Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metabolism Reviews 41 (2) : 77-88. ScholarBank@NUS Repository. https://doi.org/10.1080/03602530902741828
Abstract: Gemcitabine is a cytotoxic nucleoside analog, which is widely used in the treatment of malignancies. Interindividual differences in gemcitabine pharmacokinetics and pharmacodynamics have been demonstrated. Pharmacogenetic factors may account for a significant proportion of these differences. This review provides an update on the pharmacogenetics of gemcitabine and its influence on gemcitabine efficacy and toxicity. © 2009 Informa UK Ltd.
Source Title: Drug Metabolism Reviews
URI: http://scholarbank.nus.edu.sg/handle/10635/115536
ISSN: 03602532
DOI: 10.1080/03602530902741828
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

82
checked on Jan 16, 2018

WEB OF SCIENCETM
Citations

73
checked on Nov 22, 2017

Page view(s)

23
checked on Jan 14, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.